Literature DB >> 6671086

Inhibition of the in vitro formation of irreversibly sickled cells by cepharanthine.

S T Ohnishi.   

Abstract

A method was developed to prepare irreversibly sickled cells (ISC) in vitro under a physiological condition. By exposing sickle red cells to repeated deoxygenation-reoxygenation cycles for 15 h at 37 degrees C, 20-30% of the red cells formed ISC. These cells were separated from biconcave-shaped cells by a gradient density centrifugation. The percentage of the formation of ISC was determined spectrophotometrically after cells were haemolysed. Cepharanthine, a bisbenzylisoquinoline alkaloid, was found to inhibit this in vitro formation of irreversibly sickled cells by 50% at 15 microns. This concentration was much lower than that required to inhibit the in vitro sickling.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6671086     DOI: 10.1111/j.1365-2141.1983.tb02849.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  5 in total

1.  Light-scattering study of depolymerization kinetics of sickle hemoglobin polymers inside single erythrocytes.

Authors:  J Peetermans; I Nishio; S T Ohnishi; T Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

Review 2.  Membrane transport of Na and K and cell dehydration in sickle erythrocytes.

Authors:  C Brugnara
Journal:  Experientia       Date:  1993-02-15

3.  Evidence for a direct reticulocyte origin of dense red cells in sickle cell anemia.

Authors:  R M Bookchin; O E Ortiz; V L Lew
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

4.  Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes.

Authors:  S T Ohnishi; K K Sadanaga; M Katsuoka; W P Weidanz
Journal:  Mol Cell Biochem       Date:  1989 Nov 23-Dec 19       Impact factor: 3.396

Review 5.  Cepharanthine: An update of its mode of action, pharmacological properties and medical applications.

Authors:  Christian Bailly
Journal:  Phytomedicine       Date:  2019-05-10       Impact factor: 5.340

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.